Commercially available AI systems excel in detecting cancer in dense breasts

The combination of AI with digital mammography (DM) and automated 3D breast ultrasound (ABUSE) may be especially beneficial for detecting cancer in women dense breasts.

According to a new article published on January 16 in Preview imageryadding two commercially available AI systems can achieve equal or greater sensitivity to detect malignant tumor in dense breasts when compared to human readers.

For the study, a comparative research team 430 matched crates of DM and ABUSE interpretations of four radiologists to that of two commercially available, FDA-cleared AI systems.

Experts analyzed the detection results of AI and DM alone and AI and ABUS alone and found that a combination of the two produces the most accurate results, recording a sensitivity and specificity of 79.4% and 91.2%, respectively. Compared to radiologists, multimodal AI performed as well or better at the same specificity operating points.

The multimodal AI approach can combine information from ABUS and DM, which could be particularly beneficial.cial in resource-poor areas where experimented radiologists may not be readily available for the interpretation of screening teststhe authors of the new study suggested.